Thus, this suggested a potentially direct interaction between SARS-CoV-2 and virus-associated cancers, leading to the hypothesis that IL-6 could bridge the gap between COVID-19 and virus-mediated cancers [20]. This evidence concerns the gene IL6 and COVID-19.